Table 5.
Overall survival and disease survival rate for BMI categories across menopausal status in TNM stage
| Overall Survival times (%) | Disease Survival times (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Stage 1 | |||||||||
| 1 | 3 | 5 | P value* | 1 | 3 | 5 | P value* | ||
| Pre-menopausal | BMI<25 | 99 | 99 | 91 | 0.83 | 97 | 96 | 92 | 0.31 |
| 25.0≤BMI< 30.0 | 100 | 99 | 95 | 96 | 93 | 89 | |||
| BMI ≥30 | 100 | 99 | 90 | 97 | 96 | 94 | |||
| Post-menopausal | BMI<25 | 100 | 100 | 85 | 0.91 | 99 | 97 | 94 | 0.25 |
| 25.0≤BMI< 30.0 | 100 | 100 | 91 | 98 | 97 | 94 | |||
| BMI ≥30 | 99 | 98 | 96 | 96 | 95 | 90 | |||
| Stage 2 | |||||||||
| Pre-menopausal | BMI<25 | 100 | 98 | 88 | 0.43 | 96 | 92 | 88 | 0.35 |
| 25.0≤BMI< 30.0 | 100 | 99 | 93 | 98 | 93 | 91 | |||
| BMI ≥30 | 99 | 99 | 81 | 96 | 91 | 88 | |||
| Post-menopausal | BMI<25 | 100 | 100 | 85 | 0.81 | 94 | 91 | 87 | 0.09 |
| 25.0≤BMI< 30.0 | 100 | 98 | 91 | 96 | 94 | 92 | |||
| BMI ≥30 | 100 | 99 | 90 | 96 | 95 | 92 | |||
| Stage 3 | |||||||||
| Pre-menopausal | BMI<25 | 100 | 100 | 100 | 0.05 | 92 | 82 | 70 | 0.82 |
| 25.0≤BMI< 30.0 | 98 | 97 | 70 | 88 | 82 | 78 | |||
| BMI ≥30 | 100 | 97 | 78 | 91 | 85 | 81 | |||
| Post-menopausal | BMI<25 | 100 | 98 | 63 | 0.42 | 90 | 86 | 82 | 0.67 |
| 25.0≤BMI< 30.0 | 99 | 98 | 80 | 88 | 81 | 80 | |||
| BMI ≥30 | 100 | 97 | 79 | 92 | 87 | 85 | |||
* Wilcoxon (Gehan) test